FDA Inspection 739376 — Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. — FEI 3002457563

The FDA completed an inspection of Acorda Therapeutics, Inc. on Aug 11, 2011 in Pearl River, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 11, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pearl River, NY (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.